Targeted Therapy Directed by Genetic Testing in Treating Patients With Advanced Refractory Solid Tumors, Lymphomas, or Multiple Myeloma (The MATCH Screening Trial)
National Cancer Institute (NCI)
National Cancer Institute (NCI)
Jazz Pharmaceuticals
University of California, Irvine
Daiichi Sankyo
ImmunityBio, Inc.
Merck Sharp & Dohme LLC
Telix Pharmaceuticals (Innovations) Pty Limited
Apollomics Inc.
University of California, Irvine
Universitair Ziekenhuis Brussel
Catalysis SL
Eli Lilly and Company
University of California, San Diego
Wake Forest University Health Sciences
Roswell Park Cancer Institute
National Cancer Institute (NCI)
M.D. Anderson Cancer Center
National Cancer Center, Korea